Photo of Cory A. Booker
D United States Senate · New Jersey On the 2026 ballot

Sen. Cory A. Booker

Compare
Total votes
1,054
all sessions
Attendance
98%
22 missed
Near the chamber average
With party
93%
of cast votes
Lower than 95% of chamber peers
Bipartisan score
4%
crosses aisle rarely
Higher than 93% of chamber peers
Sponsored
2,570
bills & resolutions
Higher than 98% of chamber peers
Committees
14
assignments
2,570 bills and resolutions

Sponsored bills

Total
2,570
Primary
411
Co-sponsor
2,159
This page
2,570
matching current filters
Primary SRES 704
In committee · United States Senate · Lead sponsor
A resolution recognizing the strategic importance of Kenya to the United States and celebrating the 60-year anniversary of United States-Kenya relations.

Maddy summarySRES 704 is a symbolic Senate resolution commemorating 60 years of U.S.-Kenya diplomatic relations, established in 1964 after Kenya's independence. It highlights Kenya's strategic importance as a regional security partner (including counterterrorism efforts in Somalia and the Red Sea), economic hub in East Africa, and leader in democracy and environmental resilience. The resolution affirms cooperation on shared priorities like trade (under AGOA), defense (via a 2023 framework), public health (through PEPFAR), and democratic values. As a non-binding resolution, it does not create new laws but formally celebrates the partnership and encourages continued collaboration on economic, security, and people-to-people ties.

In committee May 23, 2024 0 co-sponsors
Co-sponsor S 4407
In committee · United States Senate · Co-sponsor
Elementary and Secondary School Counseling Act

Maddy summaryThis bill establishes federal grants to improve mental health services in schools by targeting high-need schools (those with high poverty rates). It requires states to use funds to recruit counselors, psychologists, and social workers to meet specific staffing ratios: 250 students per counselor/social worker and 500 students per psychologist. States must provide 20% matching funds and prioritize schools with the greatest need, with annual reporting on progress toward these ratios. The bill authorizes $5 billion for fiscal year 2025 to support these efforts, aiming to increase access to school-based mental health care for students facing mental health challenges.

In committee May 23, 2024 1 co-sponsor
Co-sponsor S 4406
In committee · United States Senate · Co-sponsor
End Polluter Welfare Act of 2024

Maddy summaryThe End Polluter Welfare Act of 2024 eliminates numerous subsidies and financial benefits for fossil fuel companies across multiple government programs. It increases royalty rates for coal and oil/gas extraction, prohibits federal funding for fossil fuel projects through various agencies, and repeals tax provisions that previously provided advantages to the fossil fuel industry. The bill directly affects fossil fuel producers by ending royalty relief, eliminating tax deductions and credits for fossil fuel production, and requiring them to pay higher taxes on crude oil and natural gas. Key mechanisms include terminating the Office of Fossil Energy, restricting international financial institutions from funding fossil fuel projects, and modifying tax rules to eliminate special treatment for fossil fuel producers.

In committee May 23, 2024 1 co-sponsor
Co-sponsor S 4426
In committee · United States Senate · Co-sponsor
Promising Pathway Act 2.0

Maddy summaryThe Promising Pathway Act 2.0 creates a new FDA pathway for conditional approval of drugs treating rare, progressive, and serious diseases. This allows patients with limited treatment options to access promising new drugs sooner, based on preliminary safety data from Phase 1 trials and effectiveness data from Phase 2 trials (or preliminary evidence for terminal pediatric rare diseases). The law requires drug sponsors to establish observational registries tracking patient outcomes, mandates specific labeling for conditionally approved drugs, and requires private health insurers and federal health care programs to cover these drugs without cost-sharing. Conditional approval is initially granted for 2 years with potential for up to 3 renewals (totaling 8 years), but can be withdrawn if safety data changes or sponsors fail to meet requirements.

In committee May 23, 2024 1 co-sponsor
Primary S 4429
In committee · United States Senate · Lead sponsor
SUPPORT Rx Act

Maddy summaryThe SUPPORT Rx Act creates a 3-year federal demonstration program to fund community pharmacies in providing addiction treatment for opioid and other substance use disorders. Eligible entities - including state health departments, pharmacy partnerships, and specialty treatment facilities - can apply for grants to establish or improve programs offering buprenorphine treatment, same-day low-barrier care (with minimal requirements for payment or identification), and medication-assisted therapy. Grant funds cover specific program costs like staff training, buprenorphine supply (up to 30 days), care continuity fees for patient transitions, and HIPAA-compliant technology, but may only be used for buprenorphine or overdose reversal drugs. Recipients must report annually on patient outcomes and program metrics, with results summarized in a congressional report after the demonstration ends.

In committee May 23, 2024 0 co-sponsors
Primary S 4435
In committee · United States Senate · Lead sponsor
Families Over Fees Act of 2024

Maddy summaryS 4435, the Families Over Fees Act of 2024, targets fees charged to incarcerated individuals and their families purchasing goods or services within correctional facilities. It requires businesses in prisons (like commissaries or phone services) to clearly show the total price - including all mandatory fees - in ads and at checkout, bans excessive fees (defined by cost reasonableness and available alternatives), and mandates full refunds for undelivered or defective items. Enforcement is led by the Federal Trade Commission and states, allowing lawsuits by affected consumers or state attorneys general. The law specifically applies to transactions within correctional facilities, not general consumer markets.

In committee May 23, 2024 0 co-sponsors
Co-sponsor SRES 174
Passed · United States Senate · Co-sponsor
A resolution condemning the human rights record of the Government of the Kingdom of Eswatini and the brutal killing of Eswatini activist Thulani Maseko on January 21, 2023.

Maddy summaryThis Senate resolution (SRES 174) condemns Eswatini's government for its human rights abuses and specifically the killing of activist Thulani Maseko on January 21, 2023. It calls on Eswatini to investigate Maseko's murder fully and impartially, end harassment of human rights advocates, uphold freedoms of speech and assembly, and begin a credible national dialogue on democratic reforms. The resolution also urges the U.S. government to support human rights defenders and consider sanctions against those violating rights. As a non-binding resolution, it does not create new laws but expresses the Senate's position and demands specific actions from Eswatini's government.

Passed May 22, 2024 1 co-sponsor
Co-sponsor S 4388
In committee · United States Senate · Co-sponsor
Shadow Docket Sunlight Act of 2024

Maddy summaryThis bill requires the Supreme Court to publish written explanations and disclose individual justice votes for orders granting, denying, or vacating injunctive relief or stays in cases within its appellate jurisdiction. It directly affects the Supreme Court justices and their staff when handling such orders, excluding purely administrative or scheduling requests. Key provisions mandate written reasoning and vote disclosure for these specific orders, while clarifying that the bill does not alter substantive legal standards or the Court's jurisdiction. The bill also requires the Federal Judicial Center to report annually on compliance with these new disclosure rules.

In committee May 22, 2024 1 co-sponsor
Co-sponsor S 4385
In committee · United States Senate · Co-sponsor
Enhancing Oversight to End Discrimination in Policing Act

Maddy summaryThis bill, S 4385 (Enhancing Oversight to End Discrimination in Policing Act), requires the Justice Department to revise consent decree procedures for law enforcement investigations to include community oversight bodies and non-law enforcement remedies like mental health support. It authorizes $445 million annually (2025-2034) for pattern-or-practice investigations and establishes a $150 million grant program for states to fund independent investigations, implement reforms, and develop community-based alternatives to policing (e.g., social workers). States receiving grants must report quarterly on fund use and progress, with strict rules preventing diversion of funds to regular law enforcement operations. The bill also expands investigations to include prosecutors/judges and mandates reporting on demographic data for cases involving rights violations.

In committee May 22, 2024 1 co-sponsor
Co-sponsor S 3819
In committee · United States Senate · Co-sponsor
Shrinkflation Prevention Act of 2024

Maddy summaryThis bill would require the Federal Trade Commission (FTC) to create rules preventing companies from reducing product sizes without proportionally lowering prices - a practice known as "shrinkflation." It defines shrinkflation as downsizing a product while not decreasing the price commensurately, treating violations as deceptive practices under existing FTC authority. The rules would be finalized within 18 months of the bill's enactment, with enforcement by the FTC and states allowed to sue companies for violations. The measure directly affects consumers, who face deceptive pricing, and manufacturers who would need to adjust product sizing and pricing transparency.

In committee May 22, 2024 1 co-sponsor
Showing 1,051 to 1,060 of 2,570 bills